Michael J. Hall, MD, MS

Michael J. Hall, MD, MS

PARP Inhibitor Olaparib Exceeds Expectations in BRCA+ Pancreatic Cancer ManagementПодробнее

PARP Inhibitor Olaparib Exceeds Expectations in BRCA+ Pancreatic Cancer Management

Clinical genetics and cytogeneticsПодробнее

Clinical genetics and cytogenetics

Michael Hall: ASCO Colon Cancer updatesПодробнее

Michael Hall: ASCO Colon Cancer updates

POLO: Olaparib as maintenance treatment for metastatic pancreatic cancerПодробнее

POLO: Olaparib as maintenance treatment for metastatic pancreatic cancer

Dr. Hall on the Importance of Genetic Testing in Pancreatic CancerПодробнее

Dr. Hall on the Importance of Genetic Testing in Pancreatic Cancer

Dr. Hall Discusses Rationale for the POLO Trial in Metastatic Pancreatic CancerПодробнее

Dr. Hall Discusses Rationale for the POLO Trial in Metastatic Pancreatic Cancer

Dr. Michael J. Hall: Vascular & interventional radiologyПодробнее

Dr. Michael J. Hall: Vascular & interventional radiology

Hereditary Colorectal CancerПодробнее

Hereditary Colorectal Cancer

Dr. Hall on Multi-Gene Target Panels for Genetic WeaknessesПодробнее

Dr. Hall on Multi-Gene Target Panels for Genetic Weaknesses

Популярное